BSL-4 Lab Worker - Photo Credit –USAMRIID
# 6130
Tying in with my last post (see Declan Butler: Lab flu may not aid vaccines), we’ve an editorial appearing today in Nature that calls into question the short-term benefits of so-called `dual use’ H5N1 research.
Follow the link to read:
Nature | Editorial
Nature 482,131
(09 February 2012) doi:10.1038/482131a
- Published online 08 February 2012
The potential for mutant-flu research to improve public health any time soon has been exaggerated. Timely production of sufficient vaccine remains the biggest challenge.
I expect that we’ll see vigorous counterpunching on this issue in the not too distant future as both sides prepare for the meeting in Geneva next week.
Stay tuned.
The stakes here are extraordinarily high, the issues are complex, and I expect no shortage of fireworks.
